慢性DeBakey IIIb型主动脉夹层中应用房间隔封堵器封闭假腔后的主动脉重塑
本回顾性研究纳入2014年1月至2020年11月在本机构接受胸主动脉腔内修复的慢性DeBakey IIIb型主动脉夹层患者,其中37例因远端破口导致假腔逆流并伴胸段动脉瘤形成,接受房间隔封堵器(ASO)封闭假腔。技术成功率为100%,随访中位36个月,5年总体生存率71%,34例(91.9%)在末次随访时治疗段假腔完全血栓化。作者认为该联合方案技术可行且有效,但需更多样本的前瞻性研究验证。
要点
- 37例慢性DeBakey IIIb型夹层伴胸段动脉瘤患者用房间隔封堵器封闭假腔,技术成功率100%。
- 末次随访时34例(91.9%)治疗段假腔完全血栓化,5年总体生存率71%。
- 随访期胸段真腔直径增加(0.256 mm/月,P < .001),假腔直径减小(-0.512 mm/月,P < .001)。
核心结论
- 在标准胸主动脉腔内修复基础上联合房间隔封堵器封闭假腔以促进治疗段假腔血栓形成与重塑,是治疗慢性DeBakey IIIb型夹层伴降主动脉瘤技术上可行且有效的替代方法。
- 该方法在本组患者中取得满意的中期生存结局和较低的主动脉相关死亡发生率。
- 作者指出,在常规临床推广该技术前,需更多样本的前瞻性设计研究验证上述发现。
研究设计与样本
- 回顾性分析本机构2014年1月至2020年11月因慢性DeBakey IIIb型主动脉夹层接受胸主动脉腔内修复的全部患者。
- 共37例(年龄56.24 ± 10.47岁)存在持续性假腔逆流灌注及胸段动脉瘤形成,接受房间隔封堵器封闭假腔。
- 主要终点为技术成功率和院内术后结果;次要终点包括中期生存状态和主动脉重塑结果。
主要发现
- 技术成功率为100%,未观察到脊髓缺血或院内死亡。
- 随访中位时间36个月(四分位距24-51个月);术后3例(8.1%)发生内漏(Ia型2例、II型1例),5例需晚期再干预。
- 5年总体生存率为71%;随访9个月时发生1例主动脉相关死亡(占总队列2.7%)。
- 末次随访CT血管造影显示34例(91.9%)治疗段假腔完全血栓化。
- 混合效应模型直径分析显示胸段真腔直径增加(0.256 mm/月,P < .001),胸段假腔直径减小(-0.512 mm/月,P < .001)。
临床怎么用
- 作者认为,标准胸主动脉腔内修复联合房间隔封堵器封闭假腔可作为慢性DeBakey IIIb型夹层伴降主动脉瘤的替代治疗,但需更多样本的前瞻性研究验证后方可常规临床推广。
局限性
- 本文为回顾性研究。
- 作者指出需更多样本及前瞻性设计的研究验证本研究结果,之后该技术方可常规用于临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Retrograde false lumen flow through distal entry tears poses a challenge in the treatment of chronic DeBakey IIIb aneurysms. In the present report, we have described the feasibility and outcomes of false lumen occlusion using an atrial septal occluder (ASO) in chronic DeBakey IIIb dissection associated with a descending aneurysm. METHODS: All the patients who had undergone thoracic endovascular aortic repair for chronic DeBakey IIIb aortic dissection at our institution from January 2014 to November 2020 were retrospectively reviewed. The primary endpoints were technical success and in-hospital postoperative results. The secondary endpoints included the midterm survival status and aortic remodeling outcomes. RESULTS: A total of 37 patients (age, 56.24 ± 10.47 years) with persistent retrograde false lumen perfusion and aneurysm formation at the thoracic segment were treated using an ASO for false lumen occlusion. We achieved 100% technical success. No spinal cord ischemia or in-hospital death was observed. The median follow-up time was 36 months (interquartile range, 24-51 months). After the procedure, three patients (8.1%) had had an endoleak (type Ia in two patients and type II in one patients), and five patients had required late reintervention. The overall 5-year survival rate was 71%. One aortic-related death (2.7% of the total cohort) occurred during follow-up at 9 months. Complete thrombosis of the false lumen along the treated aortic segment was recorded postoperatively in 34 patients (91.9%) at the final follow-up using computed tomography angiography. In a mixed-effects model, a diameter analysis revealed that the thoracic true lumen diameter had increased and the thoracic false lumen diameter had decreased significantly (0.256 mm/mo, P < .001; and -0.512 mm/mo, P < .001, respectively). CONCLUSIONS: The combination of standard thoracic endovascular aortic repair and false lumen occlusion using the ASO to promote false lumen thrombosis and remodeling in the treated segments is a technically feasible and effective alternative treatment of chronic DeBakey IIIb dissection with an associated descending aneurysm. This approach yielded satisfactory midterm survival outcomes and a low incidence of aortic-related death in our patients. However, further studies with more subjects and a prospective design should verify our findings before routine clinical implementation of this technique.
引用
- Lu H, Lin Z, Chen Y, et al. Aortic remodeling after false lumen occlusion using an atrial septal occluder in chronic DeBakey IIIb aortic dissection. J Vasc Surg. 2022. PMID: 34995720. doi:10.1016/j.jvs.2021.12.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。